Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Enforcement-nir
Subscribe today for access to
Articles and Reports
Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It
False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.
OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
FY 2021 OIG Enforcement Outcomes Continue Long-Term Downward Trend
...
Already a member? Log in here
Will the Biden Mandatory COVID-19 Vaccine Mandate Survive Court Challenge?
...
Already a member? Log in here
Labs Figure Prominently in Latest DOJ Telemedicine, COVID-19 and Sober Homes Fraud Takedown
...
Already a member? Log in here
Federal False Claims Act Recoveries Hit 5-Year High
...
Already a member? Log in here
Fraud Recoveries Grow as Feds Target Telemedicine and COVID-19 Add-On Test Scams
...
Already a member? Log in here
University of Miami Settles Lab Testing False Claim Charges for $22 Million
...
Already a member? Log in here
Health Care Data Breaches Hit a New High in First Half of 2021
...
Already a member? Log in here
Texas Provider Pays $214K for Violating Federal COVID-19 Workplace Protocols
...
Already a member? Log in here
University of Miami Settles Lab Testing False Claim Charges for $22 Million
...
Already a member? Log in here
Texas Provider Pays $214K for Violating Federal COVID-19 Workplace Protocols
...
Already a member? Log in here